Literature DB >> 24444782

Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score.

Mustafa Cetin1, Musa Cakici2, Cemil Zencir3, Hakan Tasolar2, Erkan Baysal4, Mehmet Balli2, Erdal Akturk2.   

Abstract

As the CHADS2 and CHA2DS2-VASc scores include similar risk factors for the development of coronary artery disease (CAD), they may provide crucial information regarding the severity of coronary artery lesions and the risk of thromboembolism. To increase the likelihood of determining CAD severity, we formulated the CHA2DS2-VASc-HS score comprising hyperlipidemia and smoking in addition to the components of the CHA2DS2-VASc score and male instead of female gender. We aimed to investigate whether these 3 risk scores can be used to predict CAD severity. A total of 407 consecutive patients who underwent coronary angiography were enrolled in the study. Presence of >50% stenosis in a coronary artery was assessed as significant CAD. Of the patients, 87 had normal coronary angiograms and served as group 1. The remaining 320 patients with coronary stenosis were further classified into 2 groups according to CAD with stenosis of <50% or ≥50%: 123 patients with mild CAD as group 2 and 197 patients with severe CAD as group 3. The CHADS2, CHA2DS2-VASc, and CHA2DS2-VASc-HS scores were significantly different among the 3 groups. The CHADS2, CHA2DS2-VASc, and CHA2DS2-VASc-HS scores correlated significantly with the number of diseased vessels (r = 0.406, p <0.001; r = 0.308, p <0.001; and r = 0.533, p <0.001, respectively) and the Gensini score (r = 0.383, p <0.001; r = 0.300, p <0.001; and r = 0.500, p <0.001, respectively). The CHA2DS2-VASc-HS score was found to be the best scoring scheme to predict CAD severity in the area under the curve comparison of these scoring systems. For prediction of severe CAD, the cut-off value of CHA2DS2-VASc-HS score was >2 with a sensitivity of 85.2% and a specificity of 57.5% (area under the curve 0.802, 95% confidence interval 0.760 to 0.839, p <0.001). In conclusion, our findings suggest that the CHADS2, CHA2DS2-VASc, and especially CHA2DS2-VASc-HS scores could be considered predictive of the risk of severe CAD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24444782     DOI: 10.1016/j.amjcard.2013.11.056

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Predictive value of CHA2DS2-VASc and CHA2DS2-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction.

Authors:  Salih Kilic; Umut Kocabas; Levent Hurkan Can; Oğuz Yavuzgil; Mustafa Çetin; Mehdi Zoghi
Journal:  Cardiol J       Date:  2018-03-07       Impact factor: 2.737

2.  Prediction of acute coronary syndrome, ischemic stroke, and mortality in patients with heart failure: a comparison of CHA2DS2-VASc and AHEAD scores.

Authors:  Wei-Syun Hu; Cheng-Li Lin
Journal:  J Interv Card Electrophysiol       Date:  2019-06-14       Impact factor: 1.900

3.  CHA2 DS2 -VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule-out.

Authors:  Guy Topaz; Ory Haisraely; Yacov Shacham; Gil Beery; Lotan Shilo; Nuha Kassem; David Pereg; Yona Kitay-Cohen
Journal:  Clin Cardiol       Date:  2018-04-23       Impact factor: 2.882

4.  Presence of Microvascular Dysfunction and CHA2DS2-VASc Score in Patients with ST-Segment Myocardial Infarction after Primary Percutaneous Coronary Intervention.

Authors:  Ragab A Mahfouz; Marwa M Gad; Mohamed Arab; Moei-E Deen Abulfotouh
Journal:  Pulse (Basel)       Date:  2021-11-26

5.  A Newly Defined CHA2DS2-VA Score for Predicting Obstructive Coronary Artery Disease in Patients with Atrial Fibrillation-A Cross-Sectional Study of Older Persons Referred for Elective Coronary Angiography.

Authors:  Zyta Beata Wojszel; Łukasz Kuźma; Ewelina Rogalska; Anna Kurasz; Sławomir Dobrzycki; Bożena Sobkowicz; Anna Tomaszuk-Kazberuk
Journal:  J Clin Med       Date:  2022-06-16       Impact factor: 4.964

6.  The Novel CHA2DS2-VASC-FSH Score is Predictive of Severe Coronary Artery Disease on Coronary Angiography in Patients with Atrial Fibrillation and Unstable Symptoms.

Authors:  Orcun Ciftci; Kerem Can Yilmaz; Emir Karacaglar; Mustafa Yilmaz; Bulent Ozin; Ibrahim Haldun Muderrisoglu
Journal:  Eurasian J Med       Date:  2019-06

7.  Does the CHA2DS2-Vasc score predict procedural and short-term outcomes in patients undergoing transcatheter aortic valve implantation?

Authors:  Tahir Hamid; Tawfiq R Choudhury; Simon G Anderson; Izhar Hashmi; Saqib Chowdhary; David Hesketh Roberts; Douglas G Fraser; Ragheb Hasan; Vaikom S Mahadevan; Richard Levy
Journal:  Open Heart       Date:  2015-10-22

8.  Association between modified CHA2DS2-VASc Score with Ankle-Brachial index < 0.9.

Authors:  Po-Chao Hsu; Wen-Hsien Lee; Hsiang-Chun Lee; Wei-Chung Tsai; Chun-Yuan Chu; Ying-Chih Chen; Chee-Siong Lee; Tsung-Hsien Lin; Wen-Chol Voon; Sheng-Hsiung Sheu; Ho-Ming Su
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

9.  Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation.

Authors:  Filip M Szymanski; Krzysztof J Filipiak; Anna E Platek; Anna Hrynkiewicz-Szymanska; Grzegorz Karpinski; Grzegorz Opolski
Journal:  Sleep Breath       Date:  2014-08-02       Impact factor: 2.816

10.  Association of the CHADS2 and CHA 2DS 2-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients.

Authors:  Anna Hrynkiewicz-Szymanska; Miroslaw Dluzniewski; Anna E Platek; Filip M Szymanski; Joanna Syska-Suminska; Agnieszka Klos-Szadryn; Marta Glinka; Malgorzata Strojek; Alicja Kuciej; Monika Tomaszewska-Kiecana
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.